SecBot SecBot

EVH

Evolent Health, Inc.
NYSE· Services-Management Services· Inc. DE· CIK 0001628908 Services
$4.83 −0.07 (−1.43%)
Nov 16 4:00 PM ET · prev $4.90
Market cap
$538.9M
Small cap
Consensus
Buy
78% Buy or better · 18 analysts
Median target
$6.00
+24% · range $3.00–8.00
1 year
+24.8%
from $3.87 · Nov 17
30 days
+7.8%
from $4.48
52-week range
$2.17–6.19
−22% from high · low Mar 30
Avg volume 20D
1.68M
shares / day
Short interest
10.61M
≈9.4% of shares · −10.9%
Days to cover
7.0
at average volume
Insider net
−$329.5K
0 buyers · 1 seller · 12 mo
New fund stakes
1
Q3 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read BEARISH 4 reports · 90 days
Balance 2 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/4

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $329.5K.

  • InstitutionsBULLISH

    Q3 2026: 27 added (1 new), 15 trimmed or exited.

  • AnalystsBULLISH

    14 of 18 rate it Buy or better. Median target $6.00 (+24%).

  • Short sellersSTEADY

    Short interest −10.9% to 10.61M shares. 7.0 days to cover, ≈9.4% of shares.

  • TrendUPTREND

    14% above its 50-day average.

Who's buying

13F· Q3 2026
1
new positions
0
exits
FundMoveSharesValue
MARSHALL WACE, LLPADD5,323,524$18.6M
VANGUARD PORTFOLIO MANAGEMENT LLCDOUBLED3,344,751$11.7M
GEODE CAPITAL MANAGEMENT, LLCTRIM2,049,593$7.2M
MORGAN STANLEYNEAR_EXIT1,966,456$6.9M
Qube Research & Technologies LtdDOUBLED1,518,908$5.3M
Hudson Bay Capital Management LPADD1,484,995$5.2M
Walleye Capital LLCADD1,122,301$3.9M
JPMORGAN CHASE & CODOUBLED890,825$3.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

18 analysts
Buy 78% rate it Buy or better
Strong Buy4Buy10Hold4Sell0Strong Sell0
12-month targets · 12 analysts

Price is inside the target range. Median implies +24%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 6, 2026Oppenheimer
MAINTAIN
MAINTAINOutperform
Nov 5, 2026Needham
MAINTAIN
MAINTAINBuy
Aug 18, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Aug 17, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Aug 12, 2026Truist Securities
MAINTAIN
MAINTAINHold
Aug 11, 2026Citigroup
UPGRADE
UPGRADEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$329.5K
sold · 1 insider
DateInsiderTypeValue
Aug 26, 2026
McCarthy Daniel Joseph
PRESIDENT
Aug 26, 2026
SELL$329.5K
Jul 1, 2026
Shams Aammaad
Chief Accounting Officer
Jul 1, 2026
AWARD28,790 sh
Jul 1, 2026
McCarthy Daniel Joseph
PRESIDENT
Jul 1, 2026
AWARD302,585 sh
Jul 1, 2026
Blackley Seth
Chief Executive Officer
Jul 1, 2026
AWARD446,102 sh
Jul 1, 2026
McCarthy Daniel Joseph
PRESIDENT
Jul 1, 2026
TAX W/H$26.3K
Jul 1, 2026
Blackley Seth
Chief Executive Officer
Jul 1, 2026
TAX W/H$59.1K
Jul 1, 2026
Weinberg Jonathan
General Counsel
Jul 1, 2026
TAX W/H$15.2K
Jul 1, 2026
Weinberg Jonathan
General Counsel
Jul 1, 2026
AWARD43,055 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
10,607,174
shares short
-10.9%
vs prior settlement
7.0
days to cover
≈9.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Rubicon Funds and Adam Boehler filed an amended Schedule 13G disclosing that they have ceased to be beneficial owners…
SC 13G/A · Impact 5/10
Nov 5, 2026 SEC
Evolent Health reported Q3 2026 revenue of $725.4M, up 51% YoY, and a GAAP net loss of $23.6M, narrower than the…
8-K · Impact 5/10
Nov 5, 2026 Earnings
Evolent Announces Third Quarter 2026 Results
WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company
Sep 30, 2026 Inst.
MARSHALL WACE, LLP · ADD
5,323,524 shares ($18.6M)
Sep 30, 2026 Inst.
VANGUARD PORTFOLIO MANAGEMENT LLC · DOUBLED
3,344,751 shares ($11.7M)
Aug 26, 2026 Insider
McCarthy Daniel Joseph sold 65,892 shares
PRESIDENT @ $5.00 ($329.5K)
Jul 1, 2026 Insider
Shams Aammaad was granted 28,790 shares
Chief Accounting Officer
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

8 filings · 0 bullish · 2 bearish · 2 mixed · 4 neutral
All EVH filing & press-release reports (8)